Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.67% | -28.82% | -177.39% | -567.33% | -428.72% |
| Total Depreciation and Amortization | 44.95% | 132.88% | 459.02% | -- | -- |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -10.27% | -- | -- |
| Total Other Non-Cash Items | 94.15% | 23.04% | 358.31% | 4,095.33% | 1,654.95% |
| Change in Net Operating Assets | 166.69% | 99.73% | 77.12% | -319.41% | -1,597.74% |
| Cash from Operations | 4.08% | -23.83% | -77.67% | -338.74% | -276.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | -80.42% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 162.65% | 97.16% | 207.00% | 201.05% | 67.60% |
| Repurchase of Common Stock | 44.26% | -220.68% | -70.11% | -71.65% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.68% | -53.47% | -56.39% | 1,533.24% | 762.63% |
| Foreign Exchange rate Adjustments | 93.77% | 105.93% | 107.40% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.53% | -128.44% | -172.18% | 394.47% | 761.35% |